DE69502223D1 - Neue Verwendung von 1Alpha-fluor-25-hydroxy-16-en-23-yn-cholecalciferol - Google Patents

Neue Verwendung von 1Alpha-fluor-25-hydroxy-16-en-23-yn-cholecalciferol

Info

Publication number
DE69502223D1
DE69502223D1 DE69502223T DE69502223T DE69502223D1 DE 69502223 D1 DE69502223 D1 DE 69502223D1 DE 69502223 T DE69502223 T DE 69502223T DE 69502223 T DE69502223 T DE 69502223T DE 69502223 D1 DE69502223 D1 DE 69502223D1
Authority
DE
Germany
Prior art keywords
hydroxy
cholecalciferol
fluoro
1alpha
new use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69502223T
Other languages
English (en)
Other versions
DE69502223T2 (de
Inventor
Thomas I Doran
Shian-Jan Shiuey
Milan Radoje Uskokovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE69502223D1 publication Critical patent/DE69502223D1/de
Application granted granted Critical
Publication of DE69502223T2 publication Critical patent/DE69502223T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DE69502223T 1994-03-11 1995-02-27 Neue Verwendung von 1Alpha-fluor-25-hydroxy-16-en-23-yn-cholecalciferol Expired - Fee Related DE69502223T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08212453 US5384314B1 (en) 1994-03-11 1994-03-11 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol

Publications (2)

Publication Number Publication Date
DE69502223D1 true DE69502223D1 (de) 1998-06-04
DE69502223T2 DE69502223T2 (de) 1998-10-29

Family

ID=22791087

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69502223T Expired - Fee Related DE69502223T2 (de) 1994-03-11 1995-02-27 Neue Verwendung von 1Alpha-fluor-25-hydroxy-16-en-23-yn-cholecalciferol

Country Status (22)

Country Link
US (1) US5384314B1 (de)
EP (1) EP0671387B1 (de)
JP (1) JP2659345B2 (de)
KR (1) KR100360732B1 (de)
CN (1) CN1051227C (de)
AT (1) ATE165595T1 (de)
AU (1) AU687972B2 (de)
BR (1) BR9501035A (de)
CA (1) CA2141652C (de)
CZ (1) CZ288793B6 (de)
DE (1) DE69502223T2 (de)
DK (1) DK0671387T3 (de)
ES (1) ES2116634T3 (de)
FI (1) FI112323B (de)
HU (1) HU219906B (de)
IL (1) IL112887A0 (de)
NO (1) NO307782B1 (de)
NZ (1) NZ270624A (de)
PH (1) PH31333A (de)
PL (1) PL179120B1 (de)
RU (1) RU2142803C1 (de)
ZA (1) ZA951798B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830885A (en) * 1992-03-12 1998-11-03 The Johns Hopkins University Antiproliferative vitamin D3 hybrids
US5696103A (en) * 1995-11-17 1997-12-09 Syntex (U.S.A.) Inc. Method for treating osteoporosis
SG70010A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Fluorinated vitamin d3 analogs
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
US5939408A (en) 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
US5840718A (en) * 1997-03-06 1998-11-24 Hoffmann-La Roche Inc. 22-epimeric-1,25-dihydroxy-16,22,23-triene-cholecalciferol
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
JPH10316652A (ja) * 1997-05-02 1998-12-02 Duphar Internatl Res Bv １６−デヒドロビタミンｄ化合物の製造方法
US5872113A (en) * 1997-05-16 1999-02-16 Syntex (U.S.A.) Inc. Fluorinated vitamin D3 analogs
US5919986A (en) * 1997-10-17 1999-07-06 Hoffmann-La Roche Inc. D-homo vitamin D3 derivatives
AU3390400A (en) * 1999-03-05 2000-09-21 Johns Hopkins University, The Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
DE10211555A1 (de) * 2002-03-15 2003-10-02 Imtm Inst Fuer Medizintechnolo Verwendung der Inhibitoren von Enzymen mit Aktivitäten der Aminopeptidase N und/oder der Dipeptidylpeptidase IV und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention dermatologischer Erkrankungen mit sebozytärer Hyperproliferation und veränderten Differenzierungszuständen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188345A (en) * 1978-07-26 1980-02-12 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
JPS6340975A (ja) * 1986-08-05 1988-02-22 Mitsubishi Electric Corp 階調補正方式
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
GB8915770D0 (en) * 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
GB9004544D0 (en) * 1990-03-01 1990-04-25 Leo Pharm Prod Ltd Novel treatment ii
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
ES2091515T3 (es) * 1992-05-20 1996-11-01 Hoffmann La Roche Analogos fluorados de la vitamina d3.

Also Published As

Publication number Publication date
NO950920L (no) 1995-09-12
CZ63295A3 (en) 1995-11-15
NO307782B1 (no) 2000-05-29
US5384314B1 (en) 1997-08-05
FI112323B (fi) 2003-11-28
NZ270624A (en) 1996-06-25
HU219906B (hu) 2001-09-28
CN1051227C (zh) 2000-04-12
HUT70746A (en) 1995-10-30
EP0671387A1 (de) 1995-09-13
IL112887A0 (en) 1995-06-29
RU2142803C1 (ru) 1999-12-20
CN1112918A (zh) 1995-12-06
PL307629A1 (en) 1995-09-18
PH31333A (en) 1998-07-06
US5384314A (en) 1995-01-24
NO950920D0 (no) 1995-03-10
JP2659345B2 (ja) 1997-09-30
ZA951798B (en) 1996-08-14
AU1364495A (en) 1995-09-21
ATE165595T1 (de) 1998-05-15
ES2116634T3 (es) 1998-07-16
DE69502223T2 (de) 1998-10-29
BR9501035A (pt) 1995-10-31
RU95103438A (ru) 1997-02-10
KR100360732B1 (ko) 2003-03-04
DK0671387T3 (da) 1998-10-07
PL179120B1 (pl) 2000-07-31
CZ288793B6 (cs) 2001-09-12
EP0671387B1 (de) 1998-04-29
KR950032046A (ko) 1995-12-20
FI951134A0 (fi) 1995-03-10
HU9500666D0 (en) 1995-04-28
AU687972B2 (en) 1998-03-05
CA2141652C (en) 2006-05-09
CA2141652A1 (en) 1995-09-12
FI951134A (fi) 1995-09-12
JPH07258208A (ja) 1995-10-09

Similar Documents

Publication Publication Date Title
FI972580A0 (fi) Valmisteita ja menetelmiä ihoärsytyksen vähentämiseksi
DE69612003T2 (de) Substituierte benzolaktamverbindungen als substanz-p-antagonisten
DE59914996D1 (en) Heterocyclisch substituierte amide als calpainhemmer
DE69502223D1 (de) Neue Verwendung von 1Alpha-fluor-25-hydroxy-16-en-23-yn-cholecalciferol
DE69409641D1 (de) Anwendung von indolocarbazol-derivaten zur behandlung von prostataerkrankungen
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
ATE265854T1 (de) Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
TW235294B (de)
EA199900174A1 (ru) Способ лечения биполярного расстройства
TW232007B (de)
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia
DE69428127D1 (de) Schädlingsbekämpfungsmittel
MY121344A (en) Formulated product

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee